Homologous recombination deficiency (HRD), including the pathogenic mutation in BRCA2, was frequently observed, and BRCA2 deletion was observed in 50% (hemizygous deletion 40%, homozygous deletion 10%) of cases in uLMS [51]. Here, BRCA2 is linked to hypoparathyroidism-retardation-dysmorphism syndrome.